Yousef and Finger review results of clinical treatment of 101 squamous conjunctival and corneal tumors in 99 patients with at least 6 months (mean, 22 months) of follow-up. The median age of the group ...
Ocular adnexal tumors are relatively rare but require unique diagnostic and treatment considerations given the functional importance of the eye and periocular structures and their unique metastatic ...
Conjunctival squamous cell carcinoma (conjSCC) is more prevalent and aggressive in sub-Saharan African countries compared with North America. The genomic and immunophenotypic characteristics of ...
Case series showed 5% ointment may be safe and effective for diffuse conjunctival melanoma in situ or ocular surface squamous neoplasia. HealthDay News — Compounded imiquimod 5% ointment may be safe ...
Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...
What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results